NeuroMetrix (NSDQ:NURO) announced that it launched the Quell Watch App for transcutaneous electrical nerve stimulation (TENS).
Woburn, Mass.-based NeuroMetrix’s Quell app, which is now available for download from the Apple App Store, allows users of the Quell system to personalize and manage their therapy discreetly on iPhone and Android smartphones, according to a news release.
Quell is a wearable system sold over the counter designed for knee, leg and foot pain with capabilities for tracking pain, sleep, activity and gait with customized feedback. NeuroMetrix designed the Quell app, which it touts as the first and only TENS smartwatch app, to leverage the unique features of the Apple Watch.
“The promise of wearable technology is to enhance wellness and help manage disease by empowering people to monitor and improve their own health,” NeuroMetrix president & CEO Shai Gozani said in the release. “Quell is the clear innovation leader in wearable pain relief. The natural evolution of wearable technology is to move beyond each device operating in isolation, to a situation where devices interact to maximize health outcomes.
“The initial release of the Quell Watch app provides a unique and differentiated experience for Quell users managing their chronic pain. It is an exciting and important beginning for smartwatch innovation from NeuroMetrix.”